Sirtuin 1 inhibition delays cyst formation in autosomal-dominant polycystic kidney disease

Xia Zhou1, Lucy X Fan, William E Sweeney

  • 1Department of Internal Medicine, University of Kansas Medical Center, Kansas City, Kansas 66160, USA.

Insights

Autosomal-dominant polycystic kidney disease (ADPKD) involves Sirtuin 1 (SIRT1) in kidney cyst development. Inhibiting SIRT1 slowed cyst growth in mouse models, offering new therapeutic targets for ADPKD.

Area of Science:

  • Nephrology
  • Molecular Biology
  • Genetics

Background:

  • Autosomal-dominant polycystic kidney disease (ADPKD) is a genetic disorder characterized by renal cyst formation, caused by mutations in PKD1 or PKD2.
  • The exact molecular mechanisms driving cystogenesis in ADPKD are not fully understood.

Purpose of the Study:

  • To investigate the role of nicotinamide adenine dinucleotide-dependent (NAD-dependent) protein deacetylase sirtuin 1 (SIRT1) in the pathophysiology of ADPKD.
  • To evaluate the therapeutic potential of SIRT1 inhibition in ADPKD mouse models.

Main Methods:

  • Utilized Pkd1 mutant mouse models (embryonic, postnatal, hypomorphic) to study ADPKD.
  • Examined SIRT1 expression levels and its regulation by c-MYC and TNF-α.
  • Administered pan-sirtuin and SIRT1-specific inhibitors (nicotinamide, EX-527) to assess cyst growth.
  • Analyzed the impact of SIRT1 on cell proliferation and death via Rb and p53 pathways.

Main Results:

  • SIRT1 was upregulated in Pkd1-mutant renal epithelial cells and tissues.
  • Genetic deletion or pharmacological inhibition of SIRT1 significantly delayed renal cyst formation and growth in various Pkd1 mutant mouse models.
  • SIRT1 regulates cystic epithelial cell proliferation and apoptosis through deacetylation and phosphorylation of Rb and p53.

Conclusions:

  • SIRT1 plays a critical role in ADPKD pathogenesis by influencing cystic epithelial cell behavior.
  • Targeting SIRT1 signaling presents a promising therapeutic strategy for treating ADPKD.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Nephrons01:10

Nephrons

The kidneys are intricate organs with millions of working units known as nephrons. Each nephron features two major structures: the renal corpuscle, which facilitates blood plasma filtration, and the renal tubule, which handles the glomerular filtrate. Blood supply is directly linked to the nephrons. The renal corpuscle consists of the glomerulus, a capillary network, and the Bowman's capsule, a double-walled epithelial structure that encases the glomerulus. The filtering of blood plasma happens...